HealthTech

Verdiva Bio

Verdiva Bio raises $411M Series A

$411M

Total Raised

Series A

Latest Round

2024

Founded

50+

Employees

Cambridge, MA

Updated January 1, 2025

1 min read

Quick Facts

Latest Round Size

$411M

Latest Round Date

January 2025

Verdiva Bio: Series A Funding Round

Verdiva Bio has successfully raised $411M in Series A funding.

Company Overview

Biotechnology therapeutics company

Funding Details

The Series A round was led by Atlas Venture, with participation from Polaris Partners.

Investment

Verdiva Bio plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

Atlas Venture: Verified investor in Series A
Polaris Partners: Verified investor in Series A

Key Investors

Atlas Venture

Lead Investor

Verified investor in Series A

Polaris Partners

Investor

Verified investor in Series A

Topics

verified(1243)real-funding(1243)healthtech(156)series-a(152)cambridge(27)verdiva-bio(1)

About the Author

Editorial Team

Curated funding news from verified sources

Related Company Reports

HealthTech

AccelerateStack Platform

AccelerateStack Platform raises $75M Series C at $226M valuation

AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.

DermaSensor raises $16M Series B at $85M valuation

DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...

Devoted Health Partners

Devoted Health Partners Headquarters - Office Location & Address

Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.